PerkinElmer Elects Frank Witney to Board of Directors

PerkinElmer Elects Frank Witney to Board of Directors

July 27, 2016 at 4:15 PM EDT

WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE:PKI), a global leader focused on improving the health and safety of people and the environment, today announced that Frank Witney, Ph.D., has been elected to the Company's Board of Directors.

"I am delighted to welcome Frank to PerkinElmer's Board, as he brings deep market knowledge and over 30 years of leadership experience across the life sciences, diagnostics and analytical instruments industry," said Robert Friel, Chairman and Chief Executive Officer, PerkinElmer.

Most recently, Dr. Witney served as President and Chief Executive Officer of Affymetrix, Inc. (now part of Thermo Fisher Scientific), which specialized in microarray technology and cellular analysis. Previously, Dr. Witney was President and Chief Executive Officer of Dionex Corp., a market leading ion and high performance liquid chromatography company. Prior to that, Dr. Witney first joined Affymetrix when it acquired Panomics Inc., a quantitative biology company, which he led as President and Chief Executive Officer. Dr. Witney previously held the role of President of PerkinElmer's Drug Discovery Tools division following the acquisition of Packard BioScience in 2001, where he served as President and Chief Operating Officer. Dr. Witney also held several positions at Bio-Rad Laboratories, leading that company's efforts to enter the proteomic and bioassay technologies market.

Dr. Witney was a post-doctoral fellow at the National Institutes of Health from 1980 to 1983 and holds a doctorate in molecular and cell biology from Indiana University. He earned an undergraduate degree in microbiology from the University of Illinois. He is currently Chairman of the Board for Gyros Protein Technologies AB and also holds Board positions for Cerus Corporation and Exagen Diagnostics.

About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2.3 billion in 2015, has about 8,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at

PerkinElmer, Inc.
Brian Willinsky, +1-781-663-5728

Source: PerkinElmer, Inc.

News Provided by Acquire Media

Related Links

IR Contact
(781) 663 - 6900
940 Winter Street
Waltham, MA 02451
United States

Transfer Agent

Mailing addresses
Correspondence should be mailed to:
P.O. Box 505000
Louisville, KY 40233

Overnight correspondence should be sent to:
462 South 4th Street, Suite 1600
Louisville, KY 40202

Shareholder website
Shareholder online inquiries